Save

Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease

In: Beneficial Microbes
Authors:
S.D.A. Elian Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by S.D.A. Elian in
Current site
Google Scholar
PubMed
Close
,
E.L.S. Souza Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by E.L.S. Souza in
Current site
Google Scholar
PubMed
Close
,
A.T. Vieira

Search for other papers by A.T. Vieira in
Current site
Google Scholar
PubMed
Close
,
M.M. Teixeira Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by M.M. Teixeira in
Current site
Google Scholar
PubMed
Close
,
R.M.E. Arantes Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by R.M.E. Arantes in
Current site
Google Scholar
PubMed
Close
,
J.R. Nicoli Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by J.R. Nicoli in
Current site
Google Scholar
PubMed
Close
, and
F.S. Martins Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Avenida Presidente Antônio Carlos 6627, Pampulha Campus UFMG, 31270-901 Belo Horizonte, MG, Brazil

Search for other papers by F.S. Martins in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

€36.93

Inflammatory bowel diseases (IBD) are chronic inflammatory conditions, characterised by remissions and relapses episodes, whose main manifestations are ulcerative colitis and Crohn's disease. Ulcerative colitis (UC), one of the main forms of IBD, has as standard treatment the use of corticosteroids and anti-inflammatory drugs. The use of antibiotics has been also reported, but the possible adverse effects, such as disturbance of the indigenous microbiota or resistance induction, should be taken into consideration, and thus the use of probiotics emerges as a possible alternative option of treatment. In this study, the oral administration of Bifidobacterium longum subsp. infantis BB-02 was evaluated as a preventive strategy for acute experimental UC induced in female BALB/c mice by ingestion of 3.5% dextran sulphate sodium in drinking water during 7 days. During this time, the daily disease activity index was evaluated, and on the seventh day the animals were euthanised to collect intestines and liver for analysis. Treatment with the probiotic resulted in clinical improvement of the animals. The histological and morphometric analyses showed a reduction of lesions and oedema in the gut, but there was no increase in the production of mucin. The dosage of secretory immunoglobulin A was significantly higher in the colitis group and reduced in the group treated with the probiotic. There was also a reduction in the inflammation of the colon, as demonstrated by a decrease in neutrophils infiltration, and KC/CXCL-1 levels. The intestinal permeability, which is typically increased during the onset of IBD, was also reduced by treatment with probiotic. Based on these data, it can be concluded that the bacterium B. infantis BB-02 has a probiotic potential for the attenuation of UC, but further studies should be conducted to verify the mechanism of protective action of the bacterium.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 839 268 18
Full Text Views 39 7 0
PDF Views & Downloads 46 12 0